Hyperbaric Oxygen Therapy (HBOT) involves breathing pure oxygen in a pressurized environment. In a hyperbaric oxygen therapy chamber, the air pressure is increased 2 to 3 times higher than normal air pressure. Under these conditions, a human’s lungs can gather much more oxygen than would be possible breathing pure oxygen at normal air pressure. This extra oxygen helps fight bacteria. It also triggers the release of substances called growth factors and stem cells, which promote healing.
The global Hyperbaric Oxygen therapy market is presently exhibiting significant growth and market analysis predicts that growth will steadily continue. This growth is being driven by advances in medical technology coupled with an ageing population and the subsequent rise in chronic, and age-related disease.
Uses for hyperbaric oxygen therapy are manifold. A good example is in the treatment of the full range of diabetes-related disorders. Other uses are accelerated wound-healing, decompression sickness, post-surgical infections, and even experimental procedures involving Alzheimer’s patients.
The latest market research predicts that global demand of hyperbaric oxygen therapy devices is projected to increase at a CAGR of 7.1% between 2022 and 2023, reaching a total of US$ 6.3bn in 2032.
Nowhere is the growth as rapid as in North America, which holds the largest and fastest-growing market share thanks especially to recent regulatory approvals and the rapid adoption of advanced medical procedures.
The rise of medical tourism is also helping to boost the market, while countries such as India and China in the Asia Pacific market are forecast to experience rapid growth in HBOT systems over the coming years.
Cited by: Gasworld